Composition of white matter bovine brain coated vesicles: Evidence that several components influence β-amyloid peptide to form oligomers and aggregates in vitro

Brain Research

Volumn 752, Issue 1-2, 1997, Pages 72-80

  Berg, Martin J ^a   Durrie, Robert ^a   Sapirstein, Victor S ^a   Marks, Neville ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

amyloid; A4 conjugate; A4 oligomers aggregates; apolipoprotein E isoform; clathrin coated vesicle; dimyristoyl phosphatidylcholine liposome; tau

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CATTLE; COATED VESICLE; CONTROLLED STUDY; ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN; CATTLE; CLATHRIN; COATED VESICLES; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ELECTROPHORESIS; HUMANS; INDICATORS AND REAGENTS; ISOMERISM; LIPOSOMES; RATS;

EID: 0030895799     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01445-X     Document Type: Article

References (51)

1. Aggerbeck, L.P., Wetterau, J.R., Weisgraber, K.H., Wu, C.S. and Lindgren, F.T., Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains, J. Biol. Chem., 263 (1988) 6249-6258.
2. Bouillot, C., Prochiantz, A., Rougon, G. and Allinquant, B., Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties, J. Biol. Chem., 271 (1996) 7640-7644.
3. Cataldo, A.M., Hamilton, D.J., Barnett, J.L., Paskevich, P.A. and Nixon, R.A., Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease, J. Neurosci., 16 (1996) 186-199.
4. Evans, K.C., Berger, E.P., Cho, C.G., Weisgraber, K.H. and Lansbury Jr., P.T., Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease, Proc. Natl. Acad. Sci. USA, 92 (1995) 763-767.
5. Fischer, I., Shea, T.S. and Sapirstein, V.S., Induction of lysosomal glycosidases by dibutyryl cAMP in neuroblastoma cells, Neurochem. Res., 11 (1986) 589-598.
6. Gebicke-Haerter, P.J. and Shooter, E.M., Sulfation of rat apolipoprotein E, J. Neurochem., 53 (1989) 912-916.
7. Golde, T.E., Estus, S., Younkin, L.H., Selkoe, D.J. and Younkin, S.G., Processing of the amyloid protein precursor to potentially amyloidogenic derivatives, Science, 255 (1992) 728-730.
8. Grant, K.I., Casciola, L.A.F., Coetzee, G.A., Sanan, D.A., Gevers, W. and Van der Westhuyzen, D.R., Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and accelerates receptor degradation, J. Biol. Chem., 265 (1990) 4041-4047.
9. Greenberg, S.M. and Kosik, K.S., Secreted beta-APP stimulates MAP kinase and phosphorylation of tau in neurons, Neurobiol. Aging, 16 (1995) 403-407.
10. Haass, C., Koo, E.H., Mellon, A., Hung, A.Y. and Selkoe, D.J., Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments, Nature, 357 (1992) 500-503.
11. Haass, C., Lemere, C.A., Capell, A., Citron, M., Seubert, P., Schenck, D., Lannfelt, L. and Selkoe, D., The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway, Nature Med., 1 (1995) 1291-1296.
12. Handelmann, G.E., Boyles, J.K., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E., Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neuntes by rabbit dorsal root ganglion neurons in vitro, J. Lipid Res., 33 (1992) 1677-1688.
13. Hayashi, Y., Kashiwagi, K. and Yoshikawa, K., Protease inhibitors generate cytotoxic fragments from Alzheimer amyloid protein precursor in cDNA-transfected glioma cells, Biochem. Biophys. Res. Commun., 187 (1992) 1249-1255.
14. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. and Beyreuther, K., Substitutions of Hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides, J. Mol. Biol., 228 (1992) 460-473.
15. Innerarity, T.L., Pitas, R.E. and Mahley, R.W., Lipoprotein-receptor interactions, Methods Enzymol., 129 (1986) 542-565.
16. Jarrett, J.T. and Lansbury, Jr., P.T., Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 73 (1993) 1055-1058.
17. Kounnas, M.Z., Moir, R.D., Rebeck, G.W., Bush, A.I., Argraves, W.S., Tanzi, R.E., Hyman, B.T. and Strickland, D.K., LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation, Cell, 82 (1995) 331-340.
18. LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S. and Frail, D.E., Isoform-specific binding of apolipoprotein E to β-amyloid, J. Biol. Chem., 269 (1994) 23403-23406.
19. LaDu, MJ., Pederson, T.M., Frail, D.E., Reardon, C.A., Getz, G.S. and Falduto, M.T., Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid, J. Biol. Chem., 270 (1995) 9039-9042.
20. Lansbury, P.T., Costa, P.R., Griffiths, J.M., Simon, E.J., Auger, M., Halverson, K.J., Kocisko, D.A., Hendsch, Z.S., Ashburn, T.T., Spencer, R.G.S., Tidor, B. and Griffin, R.G., Structural model for the β-amyloid fibril based on interstrand alignment of an anti-parallel-sheet comprising a C-terminal peptide, Nature Struct. Biol., 2 (1995) 990-998.
21. mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons, J. Neurosci. Res., 35 (1993) 439-444.
22. Mahley, R.W., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240 (1988) 622-630.
23. Marks, N., Berg, M.J., Chi, L.-M., Choi, J., Dume, R., Swistok, J., Makofske, R.C., Danho, W. and Sapirstein, V.S., Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles, Peptides, 15 (1994) 175-182.
24. 751 with production of amyloidogenic fragments. Comparison with synthetic peptides emulating β- and γ-secretase sites, Int. J. Pepit. Protein Res., 46 (1995) 306-313.
25. Martin, B.L., Schrader-Fischer, G., Busciglio, J., Duke, M., Paganetti, P. and Yankner, B.A., Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein, J. Biol. Chem., 270 (1995) 26727-26730.
26. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K., Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res., 541 (1991) 163-166.
27. Naslund, J., Thyberg, J., Tjernberg, L.O., Wernstedt, C., Karlstrom, A.R., Bogdanovic, N., Gandy, S.E., Lannfelt, L., Terenius, L. and Nordstedt, C., Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron, 15 (1995) 219-228.
28. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E., Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264 (1994) 850-852.
29. Nordstedt, C., Caporaso, G.L., Thyberg, J., Gandy, S.E. and Greengard, P., Identification of the Alzheimer β/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells, J. Biol. Chem., 268 (1993) 608-612.
30. Perez, R.G., Squazzo, S.L. and Koo, E.H., Enhanced release of amyloid β-protein from codon 670/671 "Swedish" mutant β-amyloid precursor protein occurs in both secretory and endocytic pathways, J. Biol. Chem., 211 (1996) 9100-9107.
31. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13 (1993) 1676-1687.
32. Pike, C.J., Walencewicz-Wasserman, A.J., Kosmoski, J., Cribbs, D.H., Glabe, C.G. and Cotman, C.W., Structure-activity analyses of β-amyloid peptides: contributions of the β(25-35) region to aggregation and neurotoxicity, J. Neurochem., 64 (1995) 253-265.
33. Price, D.L., Sisodia, S.S. and Gandy, S.E., Amyloid β amyloidosis in Alzheimer's disease, Curr. Opin. Neurol., 8 (1995) 268-274.
34. Rail Jr., S.C., Weisgraber, K.H. and Mahley, R.W., Isolation and characterization of apolipoprotein E, Methods Enzymol., 128 (1986) 273-287.
35. Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T., Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron, 11 (1993) 575-580.
36. Sanan, D.A., Weisgraber, K.H., Russell, S.J., Mahley, R.W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., Roses, A.D. and Strittmatter, W.J., Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3, J. Clin. Invest., 94 (1994) 860-869.
37. Sapirstein, V.S., Durrie, R., Berg, M.J. and Marks, N., Amyloid precursor protein is enriched in axolemma and periaxolemmal-myelin and associated clathrin-coated vesicles, J. Neurosci. Res., 37 (1994) 348-358.
38. Sapirstein, V.S., Durrie, R., Nolan, C.E. and Marks, N., Identification of membrane-bound carbonic anhydrase in white matter coated vesicles: the fate of carbonic anhydrase and other white matter coated vesicle proteins in triethyl tin-induced leukoencephalopathy, J. Neurosci. Res., 35 (1993) 83-91.
39. Sapirstein, V.S., Berg, M., Grynspan, F., Nixon, R., Shea, T. and Marks, N., Coated vesicles as a model of Alzheimer's disease, J. Neurochem., 66, Suppl. 1 (1996) S27.
40. Soto, C., Branes, M.C., Alvarez, J. and Inestrosa, N.C., Structural determinants of the Alzheimer's amyloid β-peptide, J. Neurochem., 63 (1994) 1191-1198.
41. Strittmatter, W.J. and Roses, A.D., Apolipoprotein E and Alzheimer disease, Proc. Natl. Acad. Sci. USA, 92 (1995) 4725-4727.
42. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D., Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 11183-11186.
43. Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D., Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 8098-8102.
44. Tabas, I., Lim, S., Xu, X.X. and Maxfield, F.R., Endocytosed β-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages, J. Cell Biol., 117 (1990) 929-940.
45. Terzi, E., Holzemann, G. and Seelig, J., Self-association of β-amyloid peptide(1-40) in solution and binding to lipid membranes, J. Mol. Biol., 252 (1995) 633-642.
46. Thinakaran, G., Teplow, D.B., Siman, R., Greenberg, B. and Sisodia, S.S., Metabolism of the "Swedish" amyloid precursor protein variant in Neuro2a (N2a) cells. Evidence that cleavage at the "β-secretase" site occurs in the Golgi apparatus, J. Biol. Chem., 271 (1996) 9390-9397.
47. Weisgraber, K.H., Apolipoprotein E: structure-function relationships, Adv. Protein Chem., 45 (1994) 249-302.
48. Weisgraber, K.H. and Shinto, L.H., Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity, J. Biol. Chem., 266 (1991) 12029-12034.
49. Wolozin, B., Zheng, B., Loren, D., Lesch, K.P., Lebovics, R.S., Lieberburg, I. and Sunderland, T., β/A4 domain of APP: antigenic differences between cell lines, J. Neurosci. Res., 33 (1992) 189-195.
50. Yamashiro, D.J. and Maxfield, F.R., Regulation of endocytic processes by pH, Trends Pharmacol. Sci., 9 (1988) 190-193.
51. Yokode, M., Pathak, R.K., Hammer, R.E., Brown, M.S., Goldstein, J.L. and Anderson, R.G.W., Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice, J. Cell Biol. 117 (1992) 39-46.